Sermorelin: previously FDA-approved as Geref, discontinued in 2008 for business reasons rather than safety
Beyond semaglutide, other innovative GLP-1 receptor agonist medications, such as Tirzepatide , which is also a GIP receptor agonist, are available and FDA-approved for once-weekly administration under brand names like Mounjaro (for type 2 diabetes) and Zepbound (for chronic weight management)
As researchers continue to study the ways GLP-1 receptor agonists influence sleep, there is growing optimism that these medications could reshape the treatment landscape for OSA and beyond
Click for pricing breakdown How do I prepare for B12 injections
You may need a lower dose of insulin or other treatments during this time compared to in pregnancy, or before you became pregnant
Semaglutide represents a significant advancement in weight management, offering promising benefits for those struggling with obesity and related health conditions